Transcranial magnetic stimulation (TMS) has become one of the most effective treatments available for instances of Depression that have not responded to medication. As the technology has advanced, so have
How Esketamine as a Glutamate Depression Treatment is Changing the Landscape of MDD
Major depressive disorder (MDD) is one of the leading causes of disability worldwide, affecting more than 280 million people. While traditional antidepressants have helped millions, about one-third of people with
Benefits of Exercise for Depression: On Movement, Esketamine, and TMS
Depression remains one of the most common and disabling conditions worldwide. Researchers and clinicians increasingly recognize that recovery from Depression is not “one-size-fits-all.” For some, talk therapy and medication provide
Understanding the Spravato Experience: Real Patient Results from the STRIVE Study
Depression is one of the most common mental health conditions in the world. While many people find relief through standard treatments such as oral antidepressants and psychotherapy, a significant number
Breakthrough Spravato Monotherapy Approval for Treatment-Resistant Depression
For many people living with Depression, the path to relief is not straightforward. Traditional antidepressants like SSRIs and SNRIs help millions, but some patients don’t respond at all, even after
Combatting a Low Rate of Long-Term Antidepressant Success with TMS Therapy
For decades, antidepressant medications have been the first-line treatment for major depressive disorder (MDD). While they have helped millions of people, the reality is that they often fall short—with new
Your Spravato Medication Guide: An In-Depth Review for New York City Patients
In New York City, the fast pace and constant pressure can exacerbate Depression—especially for those who’ve tried multiple antidepressants with limited success. That’s why we’ve built out a Spravato medication
New Hope for NYC: Esketamine for Anxiety and Comorbid Treatment-Resistant Depression
Depression is widespread—and even more so in high-stress environments like New York City. Despite advances in treatment, many patients—especially those contending with treatment-resistant Depression (TRD) and comorbid anxiety–find that standard
Spravato NYC: A Breakthrough Nasal Spray for Treatment-Resistant Depression
When Depression Doesn’t Respond—Hope Still Exists with the Spravato Treatment NYC Citizens Need If you’ve been living in New York City and struggling with Depression that just won’t lift, even
Understanding the Paradoxical Effect of Antidepressants
Over the years, countless patients have turned to antidepressants as a definitive answer to their complex psychological challenges. In recent years, however, researchers have continued to question conventional wisdom by